Monday, September 08, 2008 6:34:21 PM
For the sake of simplicity, how about you just provide evidence to support your claim that "distributors" (plural) dropped DNAPrint Genomics' products due to "lack of sales." The example you provided was solidly refuted by the material Sam posted, and you have not provided anything since then, to support your claim.
You made that claim in the context of insinuating that all distributors would experience "lack of sales" and drop DNAPrint's products, that it would all just lead to nothing -- which was unfounded, pure speculation that turned out to be based on a false example.
Either provide evidence supporting your claim, or withdraw it. Untrue, unfounded, harmful statements against DNAG will not be left unchallenged.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM